Although multiple mechanisms appear to contribute to castrate-resistant prostate cancer (CRPC), it has been hypothesized that one origin might be immature, AR negative, tumor-propagating cells, similar to multipotent progenitors [16], [17], [18]. The gene discussed is AR; the disease is neoplasm.